YP
NVO

YANKCOM Partnership’s Novo Nordisk NVO Stock Holding History

YANKCOM Partnership’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.11K Hold
190
– – ﹤0.01% 264
2026
Q1 		$6.98K Hold
190
– – ﹤0.01% 293
2025
Q4 		$9.67K Hold
190
– – ﹤0.01% 279
2025
Q3 		$10.5K Hold
190
– – ﹤0.01% 237
2025
Q2 		$13.1K Hold
190
– – 0.01% 222
2025
Q1 		$13.2K Buy
+190
New +$15.7K 0.01% 222

Other funds holding NVO

Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
EHC
Everett Harris & Co Los Angeles, California $8.14B AUM 14.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SRIM
Saratoga Research & Investment Management Saratoga, California $1.83B AUM 18.41% 1-Year Est. Return
MG
Markel Group Glen Allen, Virginia $13.1B AUM 15.62% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
OAM
Oppenheimer Asset Management New York $9.63B AUM 30.32% 1-Year Est. Return

YANKCOM Partnership's NVO Position: Q2 2026 in Review

YANKCOM Partnership held its Novo Nordisk (NVO) position steady in Q2 2026 at 190 shares worth $9.11K. The position accounts for ﹤0.01% of the portfolio, ranked #264.

YANKCOM Partnership first reported a position in NVO in Q1 2025 and has held it in 6 quarters since. The position peaked at $13.2K in Q1 2025. 791 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • YANKCOM Partnership held 190 shares of Novo Nordisk worth $9.11K as of Q2 2026.
  • YANKCOM Partnership left its Novo Nordisk share count unchanged in Q2 2026.
  • Novo Nordisk made up ﹤0.01% of YANKCOM Partnership's portfolio in Q2 2026, its #264 holding.
  • YANKCOM Partnership first reported a position in Novo Nordisk in Q1 2025 and has held it in 6 quarters since.
  • YANKCOM Partnership's Novo Nordisk position peaked at $13.2K in Q1 2025.
  • 791 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on YANKCOM Partnership's 13F filing for Q2 2026, filed 21 Jul 2026.